Young people needing beds urgently for their mental health needs are waiting for long periods on acute general hospital wards, before being placed on wards far from where they live, according to a new study.
FDA approves AbbVie’s 24-hour Parkinson’s infusion therapy after two CRLs
The FDA has finally approved AbbVie’s infused Parkinson’s drug for patients who don’t respond to widely used oral therapies. The drug, formerly known as ABBV-951,
October 18, 2024